EPO and acute kidney injury: While there are not currently any active clinical trials using erythropoietin for the treatment of sepsis listed on the ClinicalTrials.gov website, multiple investigators have published results from clinical trials aiming to prevent AKI in susceptible populations with mixed results [66,67,68,69,70,71], suggesting that such treatment could be beneficial in some as yet unidentified subsets of these vulnerable populations.